-+ 0.00%
-+ 0.00%
-+ 0.00%

SRx Health Solutions invests in psychedelic drugmaker Optimi Health Corp IPO

PUBT·05/21/2026 13:03:26
Listen to the news
SRx Health Solutions invests in psychedelic drugmaker Optimi Health Corp IPO
  • SRX Health Solutions invested in Optimi Health, a commercial-stage psychedelic drug manufacturer and distributor focused on GMP-grade products including psilocybin.
  • The investment followed EMJ Crypto Technologies’ AI-driven screening, which cited about 30% insider ownership at Optimi and board leadership by John James (JJ) Wilson.
  • The move comes amid improved sector sentiment tied to an April 2026 executive order aimed at accelerating psychedelic drug development and coordination with the FDA and DEA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Health Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605210900PRIMZONEFULLFEED9724701) on May 21, 2026, and is solely responsible for the information contained therein.